Keywords
nonbacterial thrombotic endocarditis
Evans Syndrome
Categories
How to Cite
Abstract
Evans syndrome is a common autoimmune disease in patients with common variable immunodeficiency disease (CVID), while non-bacterial thrombotic endocarditis (NBTE) has not been described in association with CVID. We present the case of a 60-year-old man with CVID without complications associated with his disease; that after an episode of gastroenteritis of unknown etiology, he presented an Evans syndrome and a NBTE, complicated with a stroke of the right middle cerebral artery of cardioembolic cause. Given the lack of response to treatment with high doses of corticosteroids and intravenous immunoglobulin; two pulses of cyclophosphamide were administered and mycophenolate mofetil was subsequently started with resolution of the condition. We review the main autoimmune diseases associated with CVID as well as the thrombotic complications associated with treatment with intravenous immunoglobulins. We describe NBTE and its main associations as well as its possible pathophysiology. Finally, we conclude with the hypothesis that would relate the ETNB and the CVID in the context of an Evans syndrome.
References
Bonilla, F. A., Barlan, I., Chapel, H. (2016). International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. Journal of Allergy and Clinical Immunology: In Practice, 4(1), 38–59. DOI: 10.1016/j.jaip.2015.07.025
Kitcharoensakkul, M., Cooper, M. A. (2020). Autoimmunity in Primary Immunodeficiency Disorders. In The Autoimmune Diseases (pp. 513–532). DOI:10.1016/B978-0-12-812102- 3.00028-23INMUNODEFICIENCIA COMÚN Y ENDOCARDITIS PÉREZ-JAÉN, A et al.
Gathmann, B., Mahlaoui, N. (2014). Clinical picture and treatment of 2212 patients with common variable immunodeficiency. Journal of Allergy and Clinical Immunology, 134(1). DOI: 10.1016/j.jaci.2013.12.1077
Wang, J., Cunningham-Rundles, C. (2005). Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). Journal of Autoimmunity, 25(1), 57–62. DOI: 10.1016/j.jaut.2005.04.006
Feuille, E. J., Anooshiravani, N. (2018). Autoimmune Cytopenias and Associated Conditions in CVID: a Report From the USIDNET Registry. Journal of Clinical Immunology, 38(1), 28–34. DOI: 10.1007/s10875-017-0456-9
Chapel, H., Lucas, M. (2012). Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. Journal of Allergy and Clinical Immunology, 130(5), 1197-1198.e9.
DOI:10.1016/j.jaci.2012.05.046
Azizi, G., Abolhassani, H.. (2017). Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Review of Clinical Immunology, 13(2), 101–115. DOI: 10.1080/1744666X.2016.1224664
Abbott JK, Gelfand EW. (2015). Common Variable Immunodeficiency: Diagnosis, Management, and Treatment. Immunol Allergy Clin North Am. Nov;35(4):637-58. DOI:10.1016/j.iac.2015.07.009
Cherin P, Marie I, Michallet M,et al. (2016) Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence. Autoimmun Rev. Jan;15(1):71-81. DOI:10.1016/j.autrev.2015.09.002
Ramírez E, Romero-Garrido JA, López-Granados E, et al. (2014) Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: results from a retrospective cohort study. Thromb Res. Jun;133(6):1045-51. DOI:10.1016/j.thromres.2014.03.046
Marie I, Maurey G, Hervé F, et al. (2006). Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature. Br J Dermatol. Oct;155(4):714-21. DOI:10.1111/j.1365-2133.2006.07390.x
Azizi G, Abolhassani H, Asgardoon MH, Shaghaghi S, et al. (2016) Managing patients with side effects and adverse events to immunoglobulin therapy. Expert Rev Clin Pharmacol. 9(1):91-102. DOI:10.1586/17512433.2016.1105131
Liu, J., Frishman, W. H. (2016). Nonbacterial Thrombotic Endocarditis: Pathogenesis, Diagnosis, and Management. Cardiology in Review, 24(5), 244–247. DOI: 10.1097/CRD.0000000000000106
Lee, J. L., Naguwa, S. M. (2009). Revisiting Libman-Sacks endocarditis: A historical review and update. Clinical Reviews in Allergy and Immunology, 36(2–3), 126–130. DOI: 10.1007/s12016-008-8113-y
Byrnes, J. R., Wolberg, A. S. (2017). Red blood cells in thrombosis. Blood, 130(16), 1795–1799. DOI: 10.1182/blood2017-03-745349
Lecouffe-Desprets, M., Néel, A. (2015). Venous thromboembolism related to warm autoimmune hemolytic anemia: A case control study. Autoimmunity Reviews, 14(11),1023–1028. DOI: 10.1016/j.autrev.2015.07.001
Audia, S., Bach, B., Samson, M., Lakomy, D., Bour, J. B., Burlet, B., . . . Bonnotte, B. (2018). Venous thromboembolic events during warm autoimmune hemolytic anemia. PLoS ONE, 13(11), 1–13. DOI:10.1371/journal.pone.0207218
Barcellini W, et al. (2014) Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood,124(19):2930–6. DOI: 10.1182/blood-2014-06-583021
L’Acqua, C., Hod, E. (2015). New perspectives on the thrombotic complications of haemolysis. British Journal of Haematology, 168(2), 175–185. DOI:10.1111/bjh.13183
Ataga, K. I. (2009). Hypercoagulability and thrombotic complications in hemolytic anemias. Haematologica, 94(11), 1481–1484. DOI:10.3324/haematol.2009.013672
Bordin G, Boldorini R, (2003). The two hit hypothesis in the antiphospholipid syndrome: Acute ischaemic heart involvement after valvular replacement despite anticoagulation in a patient with secondary APS. Lupus.12:851–3. DOI:10.1191/0961203303lu445cr
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2021 Revista de Medicina Clínica